Form 4: Wave Life Sciences Officer Exercises and Disposes of Ordinary Shares
SEC Form 4 Filing
Chandra Vargeese, Chief Technology Officer of Wave Life Sciences, executed share options and disposed of ordinary shares on March 4, 2025.
Summary
- On March 4, 2025, Chandra Vargeese, Chief Technology Officer of Wave Life Sciences, exercised share options to acquire 91,754 ordinary shares at a price of $2.48 per share.
- Vargeese then disposed of 91,754 ordinary shares.
- Following these transactions, Vargeese beneficially owns 362,687 ordinary shares.
- The exercised share options were fully vested.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing an officer's stock transactions, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company officers.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company officer.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of transaction: Exercise of share options and disposal of ordinary shares. |
| 03/05/2025 | Date of signature. |
| 03/10/2025 | Expiration date of share options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.